AnaPonceKiessMD

Radiation Oncology • Baltimore, MD

Head & Neck, Skin Cancer

Assistant Professor, Residency Program Director of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Kiess is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kiess' full profile

Already have an account?

Office
401 North Broadway Street
Weinberg BLDG, Floor-L1 (Lobby Level)
Baltimore, MD 21287
Phone+1 410-955-6980

Fax+1 410-502-1419

Education & Training

Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2009 - 2013
University of North Carolina HospitalsResidency, Internal Medicine, 2008 - 2009
Duke University School of MedicineClass of 2008

Certifications & Licensure

DC State Medical License 2019 - 2026
MD State Medical License 2013 - 2026
VA State Medical License 2024 - 2026
NY State Medical License 2009 - 2014
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck Start of enrollment: 2019 Jan 10
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma Start of enrollment: 2024 Jul 01
Not yet recruiting
Phase 2
Roles: Contact, Principal Investigator
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization Start of enrollment: 2024 May 01
Not yet recruiting
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts.
Jack Andrews, Yohan Kim, Edlira Horjeti, Ali Arafa, Heather Gunn
Clinical Cancer Research. 2025-01-16
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.
Jarey H Wang, Matthew P Deek, Adrianna A Mendes, Yang Song, Amol Shetty
Radiotherapy and Oncology. 2025-01-01
2 citations
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Matthew P Deek, Philip Sutera, Yuezhou Jing, Robert Gao, Emily Rothman
European Urology Oncology. 2024-12-01

Journal Articles

Pattern of Planned Systemic Therapy Usage in Newly Diagnosed, Nonmetastatic Squamous Cell Carcinoma of the Head and Neck in a Commercially Insured Population in the Un...
Christine G Gourin, Ranee Mehra, Hyunseok Kang, Arlene A Forastiere, Ana P Kiess, Head & Neck

Press Mentions

Radiopharmaceuticals in Prostate Cancer: Key Considerations and New DevelopmentsJanuary 9th, 2025
7 Trends in Radiation Therapy at ASTRO 2021December 14th, 2021
‘Contrary’ to Wide Belief, Abscopal Effect Is Rare in CancerJanuary 7th, 2021
Join now to see all

Other Languages

Spanish

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ana-kiess